Using cost-effectiveness for subsidy decisions

被引：2

作者：

Glasziou, P ^{[1
]}

机构：

[1] Univ Queensland, Sch Med, Dept Social & Prevent Med, Herston, Qld 4006, Australia

来源：

HEART | 1998年 / 79卷 / 01期

关键词：

D O I：

10.1136/hrt.79.1.7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：7 / 8

页数：2

共 7 条

[1]

ARISTIDES M, 1997, HEART, V78, P12

[2] AN EVIDENCE BASED APPROACH TO INDIVIDUALIZING TREATMENT [J].

GLASZIOU, PP ;

IRWIG, LM .

BMJ-BRITISH MEDICAL JOURNAL, 1995, 311 (7016) :1356-1359

[3]

GLASZIOU PP, 1996, QUALITY LIFE PHARM C

[4] Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease [J].

Johannesson, M ;

Jonsson, B ;

Kjekshus, J ;

Olsson, AG ;

Pedersen, TR ;

Wedel, H .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (05) :332-336

[5] COST-EFFECTIVENESS OF THROMBOLYTIC THERAPY WITH TISSUE-PLASMINOGEN ACTIVATOR AS COMPARED WITH STREPTOKINASE FOR ACUTE MYOCARDIAL-INFARCTION [J].

MARK, DB ;

HLATKY, MA ;

CALIFF, RM ;

NAYLOR, CD ;

LEE, KL ;

ARMSTRONG, PW ;

BARBASH, G ;

WHITE, H ;

SIMOONS, ML ;

NELSON, CL ;

CLAPPCHANNING, N ;

KNIGHT, JD ;

HARRELL, FE ;

SIMES, J ;

TOPOL, EJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (21) :1418-1424

[6] Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death [J].

Owens, DK ;

Sanders, GD ;

Harris, RA ;

McDonald, KM ;

Heidenreich, PA ;

Dembitzer, AD ;

Hlatky, MA .

ANNALS OF INTERNAL MEDICINE, 1997, 126 (01) :1-12

[7]

1995, GUIDELINES PHARM IND

← 1 →